Clinical trial
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens…
NCT00275535 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275535 |
|---|---|
| Title | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients |
| Official title | A Prospective, Randomized Trial of Calcineurin-Inhibitor Withdrawal in Renal Allograft Recipients |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry Genzyme, a Sanofi Company Roche Pharma AG |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | Anti-thymocyte globulin, Mycophenolate mofetil, Prednisone, Tacrolimus, Sirolimus |
| Enrollment | 165 |
| Start date | Apr 1, 2001 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Jan 12, 2006 |
| Last update posted | Dec 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: